Financial Performance - The company's operating revenue for the third quarter reached ¥608,843,952.69, representing a year-on-year increase of 21.42%[4] - The total profit for the period was ¥98,303,105.16, reflecting a growth of 24.35% compared to the same period last year[4] - The net profit attributable to shareholders was ¥85,348,767.25, which is an increase of 28.58% year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥80,954,805.57, up by 28.93% from the previous year[4] - Total operating revenue for the first three quarters of 2025 reached ¥1,604,604,873.92, an increase of 11.8% compared to ¥1,435,307,024.26 in the same period of 2024[22] - Net profit for the first three quarters of 2025 was ¥184,540,169.65, a decrease of 19.2% from ¥228,401,237.25 in the same period of 2024[23] Earnings and Shareholder Information - The basic earnings per share for the period was ¥0.08, reflecting a 60.00% increase[5] - The diluted earnings per share also stood at ¥0.08, with a similar increase of 60.00%[5] - Basic earnings per share for the first three quarters of 2025 were ¥0.16, down from ¥0.19 in the same period of 2024[23] - Total number of common shareholders at the end of the reporting period is 23,809[11] - The top 10 shareholders hold a total of 1,000,000,000 shares, representing 84.54% of the total shares[11] - Hefei Qizhong Technology Holding Co., Ltd. holds 397,127,159 shares, accounting for 33.40% of total shares[11] Research and Development - Research and development expenses totaled ¥50,219,059.32, accounting for 8.25% of operating revenue, a decrease of 0.04 percentage points[5] - Research and development expenses increased to ¥142,529,783.14 in 2025, compared to ¥109,761,777.71 in 2024, marking a rise of 29.8%[22] Assets and Liabilities - The total assets of the company at the end of the reporting period were ¥7,290,769,173.61, an increase of 4.29% from the end of the previous year[5] - The company's total assets as of the end of the reporting period were ¥7,290,769,173.61, up from ¥6,991,013,658.68 at the end of the previous year, indicating a growth of 4.3%[19] - Total liabilities increased to ¥1,276,313,424.96, compared to ¥987,721,636.48 in the previous year, representing a significant increase of 29.2%[19] - The company's equity attributable to shareholders reached ¥6,014,455,748.65, slightly up from ¥6,003,292,022.20, showing a marginal increase of 0.02%[19] Cash Flow and Investments - The cash flow from operating activities for the year-to-date was ¥380,382,395.09, showing a decrease of 20.55% compared to the previous year[4] - Cash inflow from operating activities for the first three quarters of 2025 reached approximately $1.87 billion, an increase from $1.77 billion in the same period of 2024, representing a growth of about 6.2%[25] - Net cash flow from operating activities decreased to approximately $380.38 million in 2025 from $478.74 million in 2024, a decline of about 20.5%[25] - Total cash inflow from investment activities significantly increased to approximately $6.16 billion in 2025, compared to $3.44 billion in 2024, marking an increase of about 79.5%[26] - Net cash flow from investment activities showed a loss of approximately $408.85 million in 2025, an improvement from a loss of $1.16 billion in 2024[26] - Cash inflow from financing activities increased to approximately $387.22 million in 2025, compared to $139.68 million in 2024, representing a growth of about 177.5%[26] - Net cash flow from financing activities improved to approximately $44.86 million in 2025, compared to a net outflow of $323.03 million in 2024[26] - The cash and cash equivalents at the end of the period for 2025 stood at approximately $990.62 million, a decrease from $1.15 billion in 2024[26] - The company received approximately $6.15 billion from investment recoveries in 2025, a significant increase from $3.43 billion in 2024, indicating strong investment performance[25] - Cash paid for the purchase of fixed assets and other long-term assets was approximately $509.22 million in 2025, down from $895.53 million in 2024, reflecting a reduction in capital expenditures[26] Share Repurchase - The company has repurchased a total of 8,714,483 shares, which is 0.73% of the total share capital of 1,189,037,288 shares[14] - The highest repurchase price was RMB 11.86 per share, and the lowest was RMB 11.10 per share, with a total expenditure of RMB 100,398,688.97[15] - The company plans to use repurchased shares for employee stock ownership plans or equity incentives in the future[13] Accounting Standards - The company will not apply new accounting standards or interpretations starting from 2025, maintaining consistency in financial reporting[27]

Core Viewpoint - The stock price of Qizhong Technology (688352) increased by 5.12% this week, closing at 13.55 yuan, with a total market capitalization of 16.111 billion yuan as of October 24, 2025 [1] Company Announcements - Qizhong Technology received approval from the China Securities Regulatory Commission (CSRC) for the registration of its convertible bonds, allowing the company to issue these bonds to unspecified investors [1] - The approval is valid for 12 months from the date of registration, and the company is required to complete the issuance within this period [1] - The company's board of directors will handle the issuance matters within the scope authorized by the shareholders' meeting and will fulfill information disclosure obligations in a timely manner [1]

Group 1 - The stock price of XD Qizhong Technology (688352) closed at 13.09 yuan on October 22, 2025, with an increase of 0.31% and a turnover rate of 2.79% [1] - The trading volume was 102,000 hands, with a total transaction amount of 133 million yuan [1] - On October 22, the net outflow of main funds was 3.6835 million yuan, accounting for 2.77% of the total transaction amount [3] Group 2 - The company received approval from the China Securities Regulatory Commission (CSRC) for the issuance of convertible bonds to unspecified objects [1] - The approval is valid for 12 months from the date of registration and requires the company to report any significant events to the Shanghai Stock Exchange during this period [1] - The board of directors will handle the issuance matters within the scope authorized by the shareholders' meeting and fulfill information disclosure obligations based on progress [1]

Core Points - The company has received approval from the China Securities Regulatory Commission (CSRC) for the issuance of convertible bonds to unspecified investors [1][2] - The approval is valid for 12 months from the date of registration [2] - The company is required to report any significant events to the Shanghai Stock Exchange before the completion of the bond issuance [2] Company Actions - The company will proceed with the issuance of convertible bonds in accordance with the submitted documents and issuance plan [1][2] - The board of directors will handle the related matters within the authorization of the shareholders' meeting [2] - The company commits to timely fulfill information disclosure obligations as per relevant regulations [2]

Group 1 - The core point of the article is that Qizhong Technology has received approval from the China Securities Regulatory Commission to issue convertible bonds to unspecified investors [2][3] - The approval allows the company to issue convertible bonds in accordance with the submitted documents and issuance plan to the Shanghai Stock Exchange [2] - The approval is valid for 12 months from the date of consent, and the company must report any significant events to the Shanghai Stock Exchange before the issuance is completed [2]

Group 1 - Pinggao Electric reported a 6.98% increase in revenue to 8.436 billion yuan and a 14.62% increase in net profit to 982 million yuan for the first three quarters of 2025 [1] - Wanchen Group achieved a 77.37% increase in revenue to 36.562 billion yuan and a staggering 917.04% increase in net profit to 855 million yuan for the first three quarters of 2025 [2] - Xintian's revenue decreased by 10.42% to 481 million yuan, with a net profit decline of 35.19% to 91.9 million yuan for the first three quarters of 2025 [3] Group 2 - Chuangye Heima reported a revenue drop of 35.68% to 102 million yuan and a net loss of 24.93 million yuan for the first three quarters of 2025 [4] - Huaxin New Materials saw a 16.11% increase in revenue to 265 million yuan and an 18.56% increase in net profit to 40.81 million yuan for the first three quarters of 2025 [5] - Meihua Medical's revenue increased by 3.28% to 1.194 billion yuan, but net profit fell by 19.25% to 208 million yuan for the first three quarters of 2025 [6] Group 3 - Silica Technology reported a 24.30% increase in revenue to 2.651 billion yuan and a 44.63% increase in net profit to 229 million yuan for the first three quarters of 2025 [7] - Anada experienced a revenue decline of 6.03% to 1.31 billion yuan and a net loss of 46.37 million yuan for the first three quarters of 2025 [8] - StarNet Ruijie achieved a 19.20% increase in revenue to 14.168 billion yuan and a 31.06% increase in net profit to 344 million yuan for the first three quarters of 2025 [9] Group 4 - New Link Electronics reported a revenue decrease of 0.37% to 550 million yuan but a significant net profit increase of 421.43% to 535 million yuan for the first three quarters of 2025 [10] - Tianyin Electromechanical's revenue fell by 22.75% to 581 million yuan, with a net profit decline of 56.10% to 24.27 million yuan for the first three quarters of 2025 [11] - Hengtong Co. reported a revenue decrease of 39.29% to 1.05 billion yuan, but a net profit increase of 78.33% to 176 million yuan for the first three quarters of 2025 [12] Group 5 - Xigao Institute achieved a 15.05% revenue increase to 651 million yuan and a 21.28% net profit increase to 198 million yuan for the first three quarters of 2025 [13] - Good Housewife reported a revenue decrease of 0.91% to 1.059 billion yuan and a net profit decline of 24.79% to 143 million yuan for the first three quarters of 2025 [14] - China Pharmaceutical's subsidiary received approval for Vitamin B6 injection, indicating a positive development in its product pipeline [20] Group 6 - Xi Zhong Technology received approval for the issuance of convertible bonds, indicating potential for future capital raising [22] - Chengda Bio signed a strategic cooperation agreement with the Chinese Academy of Microbiology, focusing on infectious disease prevention [25] - Fuyuan Pharmaceutical received a drug registration certificate for Dydrogesterone tablets, enhancing its product offerings [26] Group 7 - Zhehai Deman received 8.1202 million yuan in land acquisition compensation, indicating a successful resolution of land-related issues [27] - Zhongjin Irradiation announced the resignation of its deputy general manager, indicating potential changes in management [29] - Hendi Pharmaceutical received a drug registration certificate for Febuxostat tablets, expanding its product portfolio [30] Group 8 - David Medical's subsidiary received a medical device registration certificate for a surgical stapler, enhancing its product offerings [32] - Liaoning Energy announced plans for a share reduction by a major shareholder, indicating potential changes in ownership structure [34] - Fengyuan Co. signed a framework agreement for the supply of lithium iron phosphate, indicating growth in its supply chain [35] Group 9 - Shengda Resources announced the resumption of construction at a mining site, indicating recovery from previous operational disruptions [37] - Shiyuan Co. reported a revenue increase of 5.45% to 18.087 billion yuan, but a net profit decline of 6.81% to 867 million yuan for the first three quarters of 2025 [39] - Feilida reported a revenue decrease of 6.81% to 4.659 billion yuan, but a net profit increase of 49.1% to 33.19 million yuan for the first three quarters of 2025 [40] Group 10 - Changyuan Donggu reported a revenue increase of 29.75% to 1.648 billion yuan and a net profit increase of 76.71% to 274 million yuan for the first three quarters of 2025 [41] - Liyuanheng reported a net profit of 47.49 million yuan for the first three quarters of 2025, indicating stable performance [42] - Fangyuan Co. reported a net loss of 121 million yuan for the first three quarters of 2025, indicating challenges in its operations [43] Group 11 - China Mobile reported a revenue increase of 0.4% to 794.7 billion yuan and a net profit increase of 4% to 115.4 billion yuan for the first three quarters of 2025 [44] - Huangshanghuang reported a revenue decrease of 5.08% to 1.379 billion yuan but a net profit increase of 28.59% to 101 million yuan for the first three quarters of 2025 [46] - Youcai Resources announced plans to invest approximately 150 million yuan in a new materials production base project [47] Group 12 - Huawei Technology announced plans to invest up to 20 million euros in two German subsidiaries [49] - China Shipbuilding projected a net profit increase of 144.42% to 170.85% for the first three quarters of 2025, indicating strong performance [51] - Aeston's subsidiary plans to transfer a 48% stake in a company for 245 million yuan, indicating strategic divestment [52] Group 13 - Jinxinno plans to raise up to 292 million yuan through a private placement, indicating potential for expansion [53] - China Power Construction reported a 5.04% increase in new contract amounts to 904.527 billion yuan for the first three quarters of 2025 [54] - Helitai reported a net profit increase of 101.45% to 17.81 million yuan for the first three quarters of 2025 [55] Group 14 - Xuefeng Technology reported a revenue decrease of 8.28% to 4.183 billion yuan and a net profit decline of 34.6% to 394 million yuan for the first three quarters of 2025 [57] - Juzhi Technology reported a revenue increase of 21.40% to 615 million yuan and a net profit increase of 33.78% to 82.47 million yuan for the first three quarters of 2025 [59] - Jinxi Axle reported a revenue decrease of 0.11% to 872 million yuan but a net profit increase of 268.03% to 22.11 million yuan for the first three quarters of 2025 [60] Group 15 - Longsheng Technology reported a revenue increase of 10.13% to 1.810 billion yuan and a net profit increase of 36.89% to 210 million yuan for the first three quarters of 2025 [62] - Shannon Chip Creation announced plans for a share reduction by a major shareholder, indicating potential changes in ownership structure [63]

证券代码：688352 证券简称：颀中科技 公告编号：2025-056 合肥颀中科技股份有限公司 关于向不特定对象发行可转换公司债券申请 获得中国证券监督管理委员会同意注册批复的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 合肥颀中科技股份有限公司（以下简称"公司"）于近日收到中国证券监督 管理委员会出具的《关于同意合肥颀中科技股份有限公司向不特定对象发行可转 换公司债券注册的批复》（证监许可〔2025〕2298 号），现将批复文件主要内容 公告如下： 一、同意公司向不特定对象发行可转换公司债券的注册申请。 特此公告。 合肥颀中科技股份有限公司 二、公司本次发行应严格按照报送上海证券交易所的申报文件和发行方案实 施。 三、本批复自同意注册之日起 12 个月内有效。 四、自同意注册之日起至本次发行结束前，公司如发生重大事项，应及时报 告上海证券交易所并按有关规定处理。 公司董事会将根据相关法律法规及上述批复文件的要求，在公司股东会的授 权范围内办理本次向不特定对象发行可转换公司债券的相关事宜，公司将根据该 事项的进展 ...

Core Viewpoint - The company has received approval from the China Securities Regulatory Commission for the issuance of convertible bonds to unspecified investors [1] Group 1 - The company, Hefei Qizhong Technology Co., Ltd. (stock code: 688352.SH), has announced the approval for its application to issue convertible bonds [1] - The approval allows the company to raise funds through the issuance of convertible bonds to unspecified investors [1]

Core Viewpoint - The company has received approval from the China Securities Regulatory Commission for the registration of its convertible bond issuance to unspecified investors [1] Group 1 - The company, Qizhong Technology (688352.SH), has announced that it will issue convertible bonds [1] - The approval allows the company to raise funds through the issuance of convertible bonds, which can be converted into shares at a later date [1] - This move is part of the company's strategy to enhance its capital structure and support future growth initiatives [1]

Group 1 - The core point of the article is that Qizhong Technology (688352) has had its application for public issuance of convertible bonds approved and registered for effectiveness [2] - The company plans to issue convertible bonds to unspecified investors, with an expected fundraising amount of 850 million yuan [2] - The underwriting institution for this issuance is CITIC Jianzhong Securities Co., Ltd. [2]